These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7312994)

  • 21. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls.
    Orologas AG; Buckman TD; Eiduson S
    Neurosci Lett; 1986 Aug; 68(3):293-8. PubMed ID: 3748456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet monoamine oxidase activity in a never-treated chronic schizophrenic.
    Lipper S; Scandinaro DW
    Lancet; 1983 Jun; 1(8337):1333. PubMed ID: 6134117
    [No Abstract]   [Full Text] [Related]  

  • 25. [A radioisotopic assay for MAO activity in human plasma and platelet (author's transl)].
    Kobayashi S; Egashira T; Oguchi K; Fukata J; Kamijo K; Gomi K
    Rinsho Byori; 1979; 27(1):35-40. PubMed ID: 430872
    [No Abstract]   [Full Text] [Related]  

  • 26. Phosphatidylserine inhibition of monoamine oxidase in platelets of schizophrenics.
    Tachiki KH; Buckman TD; Eiduson S; Kling AS; Hullett J
    Biol Psychiatry; 1986 Jan; 21(1):59-68. PubMed ID: 3942801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of platelet aldehyde reductase in cyclophrenic depressive syndromes].
    Landowski J
    Psychiatr Pol; 1978; 12(1):1-6. PubMed ID: 652876
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of oral glucose on platelet monoamine oxidase.
    Karson CN; Bridge TP; Phelps BH; Wise CD; Potkin SG; Apostoles PS; Wyatt RJ
    Biol Psychiatry; 1982 Sep; 17(9):1011-5. PubMed ID: 7138991
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 32. Monamine oxidase in schizophrenia and other behavioral disorders.
    Murphy DL; Belmaker R; Wyatt RJ
    J Psychiatr Res; 1974; 11():221-47. PubMed ID: 4461792
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings].
    Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634
    [No Abstract]   [Full Text] [Related]  

  • 34. The schizophrenia syndrome. Examples of biological tools for subclassification.
    Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV
    J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race and platelet MAO activity in schizophrenic patients.
    Meltzer HY
    Psychiatry Res; 1988 Dec; 26(3):337. PubMed ID: 3222398
    [No Abstract]   [Full Text] [Related]  

  • 36. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet monoamine oxidase in schizophrenia.
    Belmaker RH; Reches A; Ebstein RP
    Lancet; 1977 Oct; 2(8042):821. PubMed ID: 71627
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet monoamine oxidase activity in affective disorder.
    Fieve RR; Kumbaraci T; Kassir S; Dunner DL; Cote L
    Biol Psychiatry; 1980 Jun; 15(3):473-8. PubMed ID: 7378520
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels.
    Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B
    Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.